View in EDS HTML Full Text PDF Full Text

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.

Saved in:

Bibliographic Details
Title:	Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.
Authors:	Hoch, Dennis¹ (AUTHOR), Rabaglio, Manuela¹ (AUTHOR), Grob, Tobias² (AUTHOR), von Gunten, Michael³ (AUTHOR), Beyer, Jörg¹ (AUTHOR), Akhoundova, Dilara^1,4 (AUTHOR)
Source:	Case Reports in Oncology. 2023, Vol. 16 Issue 1, p1280-1286. 7p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	16626575
DOI:	10.1159/000534177